Urine test could reduce unnecessary prostate cancer biopsies

Published by  News Archive

On 10th Mar 2020

doctor and patient

Unnecessary prostate cancer biopsies could be reduced by 60 per cent thanks to new research from the University of East Anglia.

Researchers have developed new methods to identify biomarkers for prostate cancer by combining information from multiple parts of urine samples.

It is hoped that the breakthrough could help large numbers of men avoid an unnecessary initial biopsy.

Prostate cancer is the most common cancer in men in the UK. It usually develops slowly and the majority of cancers will not require treatment in a man’s lifetime.

The most commonly used tests for prostate cancer include blood tests, a physical examination known as a digital rectal examination (DRE), an MRI scan or a biopsy.

Lead author Shea Connell from UEA’s Norwich Medical School, said: “Prostate cancer is more commonly a disease men die with rather than from.

“Current practice assesses a patient’s disease using a PSA blood test, prostate biopsy and MRI. But up to 60 per cent of men with a raised PSA level are negative for prostate cancer on biopsy.

“So it is clear that there is a considerable need for additional, more accurate, tests.

Last year, the same team unveiled an experimental new test called ‘PUR’ (Prostate Urine Risk) which diagnoses aggressive prostate cancer and predicts whether patients will require treatment up to five years earlier than standard clinical methods.

The latest research combines information from two different components in urine which further improves its use for diagnosis.

Shea Connell said: “We wanted to see if other biological information from urine could be integrated together with clinical information to create a new predictive test with even greater potential.”

The team developed the ExoMeth test by studying urine samples collected from 197 patients. They used machine learning techniques to find which specific combination of biological markers could be useful for predicting the presence of prostate cancer.

ExoMeth takes a ‘holistic view’ of urine for biomarkers by considering much more than a single fraction of the urine. By integrating cell-free RNA, cellular methylation and clinical factors all together, the research team can now much more accurately discriminate the disease status of a patient without the need for an invasive biopsy.

It provides good evidence that multiple aspects of urine can be combined to determine a patient’s disease status.

Senior author Dr Daniel Brewer, from UEA’s Norwich Medical School, said: “It’s still very early days for this research, but if ExoMeth were validated in a future study with many more patients, we could see an approximate 60 per cent reduction in unnecessary biopsies in around five years.”

The research was led by UEA, in collaboration with the Norfolk and Norwich University Hospital, the Earlham Institute, University College Dublin, and the University of Toronto.

It was funded by Movember, the Masonic Charitable Foundation, the Bob Champion Cancer Trust, the King Family, the Andy Ripley Memorial Fund, the Hargrave Foundation, the US Prostate Cancer Foundation, the Science Foundation Ireland, the Royal Irish Academy and the Irish Cancer Society.

Dr Mark Buzza, global director of biomedical research programs at men’s health charity Movember said:  “Despite advances in recent years, prostate cancer remains very difficult to diagnose and treat. That’s why we’re so excited about the Exometh test. One of the major advantages of the test is that it could remove the need for 60 per cent of invasive biopsies.

“We are delighted to have supported this project under Movember’s Global Action Plan (GAP1) Biomarker project which fosters collaboration between researchers across the globe. Bringing researchers together to collaborate rather than compete for funding allows research findings to be fast-tracked.”

Development of a multivariable risk model integrating urinary cell DNA methylation & cell-free RNA data for the detection of significant prostate cancer’ is published in the journal The Prostate on March 10, 2020.

Study medicine at UEA

More world-leading research

Latest News

  News
11 Jun 2021

India’s national government has inappropriately prioritised people for Covid-19 vaccination

India’s national government has inappropriately prioritised people for covid-19 vaccination, argue doctors and researchers in The British Medical Journal today.

Read more >
  News
10 Jun 2021

UEA to lead an international educational hub

UEA has been successful in its application to the British Council’s Education Partnership Initiative, a competitive funding scheme aimed at supporting...

Read more >
  News
QS World Rankings graphics
09 Jun 2021

UEA leaps up QS World Rankings

The University is celebrating its biggest jump in the QS World Rankings in more than a decade, following the release of the annual tables yesterday (Tuesday 8...

Read more >
  News
08 Jun 2021

Widespread improvement for UEA in Complete University Guide rankings

UEA’s School of Chemistry jumping 19 places to 6th and American Studies climbing into the top five were just two of a number of successes for the University, as...

Read more >
Are you searching for something?
  News
08 Jun 2021

Widespread improvement for UEA in Complete University Guide rankings

UEA’s School of Chemistry jumping 19 places to 6th and American Studies climbing into the top five were just two of a number of successes for the University, as...

Read more >
  News
07 Jun 2021

Climate change increases extreme rainfall and the chance of floods

University of East Anglia climate experts warn that, without urgent action, climate change will continue to cause an increase in the intensity of extreme...

Read more >
  News
05 Jun 2021

Hunger provokes hangry behaviour, even in fruit flies

New research shows humans aren’t the only ones who can turn irritable and aggressive between meals.

Read more >
  News
04 Jun 2021

Student is highlight speaker at the National Natural Sciences Student Conference

Fourth year Natural Sciences student Lewis Williams was selected as the student highlight speaker at the 4th Annual National Natural Sciences Student Conference

Read more >
  News
04 Jun 2021

This year’s Alan Katritzky Scholarship recipients announced

This year’s Alan Katritzky Scholarship has been awarded (jointly) to Daniel Elford and Afonso Froes.

Read more >
  News
03 Jun 2021

New technology ‘listens’ for endangered right whales

One of the world’s most endangered whale species could have added protection from threats posed by human marine activity, through technology developed by the...

Read more >
  News
A memorial to George Floyd
25 May 2021

One year on from George Floyd’s murder

One year ago, the murder of George Floyd sent shockwaves around the world with far-reaching impact. Many long-standing issues of injustice and discrimination...

Read more >